Recital 3, Decision_act (EU) 2023/1084

In forcesince 1 Jun 2023

Germany is of the opinion that the agreement presented in the CA document does not make it mandatory to assign biocidal products used for the disinfection of surfaces in the veterinary health care area exclusively to product-type 2. In their opinion, the CA document provides the possibility to assign, to product-type 2, biocidal products for general surface disinfection in veterinary health care area when the products are used both in human and veterinary clinics, while the biocidal product is not intended to be used in the human medical area. Germany is of the opinion that it is not the purpose of the efficacy guidance and the CA document to establish a description of the product-type, as such a description is established in Annex V to Regulation (EU) No 528/2012. For those reasons, Germany considers the use in veterinary healthcare as appropriate for product-type 3 for the biocidal product.